Cited by 147interferon and immune responsesGenomics and Chromatin DynamicsCytokine Signaling Pathways and Interactions

Protein-Protein and DNA-Protein Interactions Affect the Activity of Lymphoid-Specific IFN Regulatory Factors

Meraro, David, Hashmueli, Sharon, Koren, Belly, Azriel, Aviva, Oumard, André, Kirchhoff, Sabine, Hauser, Hansjörg, Nagulapalli, Sujatha +2 more·1999·The Journal of Immunology

Abstract

IFN regulatory factors (IRFs) constitute a family of transcription factors that are involved in IFN signaling and the development and differentiation of the immune system. Targeted gene disruption studies in mice assigned their primary role to the immune system. Two lymphoid-specific IRF members, IFN consensus sequence binding protein (ICSBP) and IRF-4, bind target DNA with greater efficiency following interaction with two transcription factors, PU.1 and E47, leading to transcriptional synergy. PU.1 and E47 are essential for proper differentiation and maturation of lymphoid cells. In addition, ICSBP interacts with two IRF members, IRF-1 and IRF-2, which also have central roles in the regulation of cell-mediated immunity. Previously, we identified a region in ICSBP, termed the IRF association domain (IAD), that is conserved in all IRFs (excluding IRF-1 and IRF-2) and is essential for its interactions with other IRF proteins. Here we show that the IAD is an independent module used by ICSBP and IRF-4 for protein-protein interactions. In addition, an IAD of IRF-2 (IAD2), necessary for interaction with ICSBP, was identified and found to be conserved in IRF-1. The IAD2 shares similar characteristics with the PEST domain that is essential for the interaction of PU.1 with IRF-4. We also show that the ICSBP DNA binding domain is indispensable for the formation of DNA binding heterocomplexes and transcriptional activity. Therefore, our results shed light on the molecular mechanisms that affect IRF activities in the immune system via discrete functional domains.

Integrity signals

Registry

Crossref · 10.4049/jimmunol.163.12.6468

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ICSBP has a conserved DNA-binding domain (DBD) at the N-terminal region and an IRF association domain (IAD) in the C-terminal region.

    “ICSBP has the DNAbinding domain (DBD) conserved in the IRF family at the Nterminal region and the IRF association domain (IAD) in the C-terminal region (Fig. 1). (2-5)”
  • Interactions with IRF-1/2 and PU.1 significantly enhance DNA-binding activity of ICSBP and are mediated through the IAD.

    “Interactions with IRF-1/2 and PU.1 significantly enhance DNA-binding activity of ICSBP and are mediated through the IAD. (5)”
  • ICSBP interacts with E47 on the element composed of an IRS-like sequence and the E2A binding site found in the Igκ 3' enhancer to activate transcription, like IRF-4.

    “ICSBP was also shown to interact with E47 (encoded by the E2A gene) on the element composed of IRS-like sequence and the E2A binding site found in the Ig k 3 9 enhancer to activate transcription, again like IRF-4. (5,32)”
  • ICSBP associates with PU.1 and stimulates activity of the Ets/IRF composite element (EICE), which contains IRS and is present in immunoglobulin κ and λ, gp91phox, scavenger receptor, TLR-4, and IL-1β genes.

    “It also associates with PU.1 and stimulates activity of the Ets/IRF composite element (EICE), which also contains IRS and is present in the immunoglobulin (Ig) k and l , gp91 phox , scavenger receptor, toll-like receptor-4 (TLR-4), and interleukin (IL)-1 b genes. (5,23,26-30)”

The citation lists haven’t been fetched yet

References 42 · Cited by 147

Authors
Meraro, D., Hashmueli, S., Koren, B., Azriel, A., Oumard, A., Kirchhoff, S., Hauser, H., Nagulapalli, S., Atchison, M. L., & Levi, B.-Z.
Affiliations
  • Technion – Israel Institute of Technology (IL)
  • Department of Gene Regulation and Differentiation, Gesellschaft für Biotechnologische Forschung , Braunschweig ,
  • Helmholtz Centre for Infection Research (DE)
  • University of Pennsylvania (US)
Corresponding author
  • Meraro, David
  • Hashmueli, Sharon
  • Koren, Belly
  • Azriel, Aviva
Venue
The Journal of Immunology
Published
1999-12
Volume
163
Issue
12
Pages
6468-6478
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W2120419169
Cited by
147
References
42
Citations by year
2026: 4 · 2025: 6 · 2024: 3 · 2023: 4 · 2022: 8 · 2021: 3 · 2020: 8 · 2019: 5 · 2018: 5 · 2017: 3 · 2016: 5 · 2015: 6 · 2014: 5 · 2013: 4 · 2012: 3
FWCI
3.89
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Immunology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
Keywords
IRF8, IRF4, IRF2, IRF1, protein-protein interaction, protein-DNA interactions, PU.1, E47, transcriptional synergy, lymphoid development, transcriptional regulation, PEST domain, cell-mediated immunity
MeSH terms
Interferon Regulatory Factor-8, Interferon Regulatory Factor-4, Proto-Oncogene Protein Spi-1, Amino Acid Sequence, Animals, DNA, DNA-Binding Proteins, Interferons, Molecular Sequence Data, Proto-Oncogene Proteins, Repressor Proteins, Transcription Factors, Transcription, Genetic, Trans-Activators, Consensus Sequence, 3T3 Cells, Protein Structure, Tertiary, Amino Acid Motifs, Interferon Regulatory Factors, Interferon Regulatory Factor-2, Mice, TCF Transcription Factors, Transcription Factor 7-Like 1 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review